{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:03:42Z","timestamp":1789603422242,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Shanghai Municipality Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.apsb.2026.06.053","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:44:14Z","timestamp":1782949454000},"page":"5944-5960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The ADP-ribosyltransferases 3 (ART3) is a novel suppressor of pathological cardiac hypertrophy by ribosylating ITGA7"],"prefix":"10.1016","volume":"16","author":[{"given":"Yilei","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuimei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3054-225X","authenticated-orcid":false,"given":"Agapios","family":"Sachinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-767X","authenticated-orcid":false,"given":"Luying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.06.053_bib1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"Mcdonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.053_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","article-title":"Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential","volume":"20","author":"Martin","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.apsb.2026.06.053_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.apsb.2026.06.053_bib4","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1016\/j.apsb.2025.05.002","article-title":"Enzyme-independent functions of HDAC3 in the adult heart","volume":"15","author":"Qian","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.06.053_bib5","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.apsb.2023.08.016","article-title":"Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis","volume":"13","author":"Yu","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.06.053_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.26599\/1671-5411.2025.03.002","article-title":"Chinese guidelines for the diagnosis and treatment of heart failure 2024","volume":"22","author":"Zhang","year":"2025","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.apsb.2026.06.053_bib7","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.apsb.2023.02.005","article-title":"The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms","volume":"13","author":"Chen","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.06.053_bib8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-024-07903-1","article-title":"Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone","volume":"633","author":"Dunn","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.053_bib9","series-title":"Integrins in cardiac form, function, and disease","year":"2023"},{"key":"10.1016\/j.apsb.2026.06.053_bib10","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1002\/ehf2.13497","article-title":"Integrins in cardiac hypertrophy: lessons learned from culture systems","volume":"8","author":"Bildyug","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.apsb.2026.06.053_bib11","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCULATIONAHA.119.043504","article-title":"Integrin \u03b21d deficiency-mediated RyR2 dysfunction contributes to catecholamine-sensitive ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Wang","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.053_bib12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ajpath.2011.12.007","article-title":"\u03921 integrin gene excision in the adult murine cardiac myocyte causes defective mechanical and signaling responses","volume":"180","author":"Li","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2026.06.053_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.864101","article-title":"Research progress on mono-ADP-ribosyltransferases in human cell biology","volume":"10","author":"Gan","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.apsb.2026.06.053_bib14","article-title":"Functional roles of ADP-ribosylation writers, readers and erasers","volume":"10","author":"Li","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.apsb.2026.06.053_bib15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41556-022-00872-5","article-title":"Poly(ADP-ribosylation) of p-TEFb by PARP1 disrupts phase separation to inhibit global transcription after DNA damage","volume":"24","author":"Fu","year":"2022","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2026.06.053_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.apsb.2024.11.001","article-title":"Reversing metabolic reprogramming by CPT1 inhibition with etomoxir promotes cardiomyocyte proliferation and heart regeneration via DUSP1 ADP-ribosylation-mediated p38 MAPK phosphorylation","volume":"15","author":"Tang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.06.053_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97898","article-title":"Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair","volume":"3","author":"Ishiwata-Endo","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2026.06.053_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/BJ20040590","article-title":"ADP-ribosylation of integrin alpha7 modulates the binding of integrin alpha7beta1 to laminin","volume":"385","author":"Zhao","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2026.06.053_bib19","doi-asserted-by":"crossref","first-page":"25273","DOI":"10.1016\/S0021-9258(19)74388-9","article-title":"Integrin alpha 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells","volume":"268","author":"Zolkiewska","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.06.053_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41586-023-06311-1","article-title":"Spatially resolved multiomics of human cardiac niches","volume":"619","author":"Kanemaru","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.053_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1745-7262.2006.00125.x","article-title":"Expression of toxin-related human mono-ADP-ribosyltransferase 3 in human testes","volume":"8","author":"Friedrich","year":"2006","journal-title":"Asian J Androl"},{"key":"10.1016\/j.apsb.2026.06.053_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCULATIONAHA.124.070454","article-title":"A proteomics-based approach for prediction of different cardiovascular diseases and dementia","volume":"151","author":"Ho","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.053_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.celrep.2016.03.012","article-title":"Single-cell lineage tracing reveals that oriented cell division contributes to trabecular morphogenesis and regional specification","volume":"15","author":"Li","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.06.053_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbaexp.2006.06.004","article-title":"Genomic organization and expression of the human mono-ADP-ribosyltransferase ART3 gene","volume":"1759","author":"Friedrich","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2026.06.053_bib25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3892\/ijmm.2014.2029","article-title":"A novel NKX2-5 loss-of-function mutation predisposes to familial dilated cardiomyopathy and arrhythmias","volume":"35","author":"Yuan","year":"2015","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.apsb.2026.06.053_bib26","doi-asserted-by":"crossref","first-page":"24367","DOI":"10.1074\/jbc.M115.666461","article-title":"MEF2d deficiency in neonatal cardiomyocytes triggers cell cycle re-entry and programmed cell death in vitro","volume":"290","author":"Estrella","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.06.053_bib27","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1110\/ps.0200602","article-title":"The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse","volume":"11","author":"Glowacki","year":"2002","journal-title":"Protein Sci"},{"key":"10.1016\/j.apsb.2026.06.053_bib28","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1016\/j.molcel.2022.08.015","article-title":"An ADP-ribosyltransferase toxin kills bacterial cells by modifying structured non-coding RNAs","volume":"82","author":"Bullen","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2026.06.053_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16613-w","article-title":"Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates Fc\u03b3R1 and Fc\u03b3R2b on murine microglia","volume":"7","author":"Rissiek","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.06.053_bib30","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.celrep.2018.07.048","article-title":"Proteomic characterization of the heart and skeletal muscle reveals widespread arginine ADP-ribosylation by the ARTC1 ectoenzyme","volume":"24","author":"Leutert","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.06.053_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCRESAHA.114.301275","article-title":"Integrins and integrin-associated proteins in the cardiac myocyte","volume":"114","author":"Israeli-Rosenberg","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.053_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/cam.18702","article-title":"The regulation of integrin function by divalent cations","volume":"6","author":"Zhang","year":"2014","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.apsb.2026.06.053_bib33","first-page":"839","article-title":"Integrin traffic\u2012the update","volume":"128","author":"De Franceschi","year":"2015","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2026.06.053_bib34","unstructured":"Burkin D, Wuebbles R. Methods of treating muscular dystrophy. US Patent 10272069."},{"key":"10.1016\/j.apsb.2026.06.053_bib35","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.yjmcc.2003.10.001","article-title":"Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models","volume":"35","author":"Liang","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.apsb.2026.06.053_bib36","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI200317295","article-title":"Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling","volume":"111","author":"Braz","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2026.06.053_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s10020-022-00492-7","article-title":"RCAN1-mediated calcineurin inhibition as a target for cancer therapy","volume":"28","author":"Lao","year":"2022","journal-title":"Mol Med"},{"key":"10.1016\/j.apsb.2026.06.053_bib38","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1101\/gad.12.16.2499","article-title":"A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type","volume":"12","author":"Chin","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.apsb.2026.06.053_bib39","article-title":"Trends in survival after a diagnosis of heart failure in the United Kingdom 2000\u20122017: population based cohort study","volume":"364","author":"Taylor","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2026.06.053_bib40","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1111\/febs.16142","article-title":"ADP-ribosyltransferases, an update on function and nomenclature","volume":"289","author":"L\u00fcscher","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2026.06.053_bib41","article-title":"How does NFAT3 regulate the occurrence of cardiac hypertrophy?.","volume":"48","author":"Hui","year":"2023","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.apsb.2026.06.053_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fmmed.2022.980717","article-title":"Calcineurin-NFAT dynamics correspond to cardiac remodeling during aortic banding and debanding, mimicking aortic valve replacement","volume":"2","author":"Lunde","year":"2022","journal-title":"Front Mol Med"},{"key":"10.1016\/j.apsb.2026.06.053_bib43","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2026.06.053_bib44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00395-021-00880-w","article-title":"AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure","volume":"116","author":"Remes","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.apsb.2026.06.053_bib45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12265-021-10154-4","article-title":"Key roles of RGD-recognizing integrins during cardiac development, on cardiac cells, and after myocardial infarction","volume":"15","author":"Schussler","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.apsb.2026.06.053_bib46","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1096\/fj.04-2511fje","article-title":"Prednisolone-induced changes in dystrophic skeletal muscle","volume":"19","author":"Fisher","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.06.053_bib47","article-title":"Minimally invasive transverse aortic constriction in mice","volume":"121","author":"Zaw","year":"2017","journal-title":"J Vis Exp"},{"key":"10.1016\/j.apsb.2026.06.053_bib48","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCULATIONAHA.121.054827","article-title":"Targeting e3 ubiquitin ligase WWP1 prevents cardiac hypertrophy through destabilizing DVL2 via inhibition of k27-linked ubiquitination","volume":"144","author":"Zhao","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.053_bib49","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/CIRCRESAHA.121.318866","article-title":"The e3 ligase TRIM16 is a key suppressor of pathological cardiac hypertrophy","volume":"130","author":"Liu","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.053_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12916-019-1469-4","article-title":"Multi-level transcriptome sequencing identifies COL1a1 as a candidate marker in human heart failure progression","volume":"18","author":"Hua","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.apsb.2026.06.053_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41597-019-0094-6","article-title":"Long non-coding and coding RNA profiling using strand-specific RNA-seq in human hypertrophic cardiomyopathy","volume":"6","author":"Liu","year":"2019","journal-title":"Sci Data"},{"key":"10.1016\/j.apsb.2026.06.053_bib52","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41467-021-21146-y","article-title":"Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes","volume":"12","author":"Maron","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.053_bib53","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","article-title":"Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy","volume":"141","author":"Ren","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.053_bib54","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jacc.2006.07.026","article-title":"Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies","volume":"48","author":"Barth","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.apsb.2026.06.053_bib55","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1038\/s41467-020-18128-x","article-title":"Cardiac dopamine d1 receptor triggers ventricular arrhythmia in chronic heart failure","volume":"11","author":"Yamaguchi","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.053_bib56","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jacc.2024.07.043","article-title":"Comprehensive proteomic profiling of human myocardium reveals signaling pathways dysregulated in hypertrophic cardiomyopathy","volume":"84","author":"Lumish","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.apsb.2026.06.053_bib57","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cell.2019.05.010","article-title":"The translational landscape of the human heart","volume":"178","author":"van Heesch","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.053_bib58","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41591-019-0673-2","article-title":"Undulating changes in human plasma proteome profiles across the lifespan","volume":"25","author":"Lehallier","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.06.053_bib59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","article-title":"Atlas of the plasma proteome in health and disease in 53,026 adults","volume":"188","author":"Deng","year":"2025","journal-title":"Cell"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:22:49Z","timestamp":1789600969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526004132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211383526004132"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.06.053","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ADP-ribosyltransferases 3 (ART3) is a novel suppressor of pathological cardiac hypertrophy by ribosylating ITGA7","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.06.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}